Very impressive lecture on the image guided future of pancreas cancer! Thank you Michael Chuong for making SF a pit stop on your international tour. But we're pretty fun right? and hopefully you took lots of those green juice recovery shots!

Thank you Sue Yom for inviting me to speak about ablative #MRgRT for #PancreaticCancer this weekend!!

What a fantastic agenda and faculty lineup 🤩🤩🤩

See you soon ✈️

It’s tough to keep up with the amazing things that Stefanie Corradini 🌟 and Luca Boldrini are doing but I’m trying!

I’m honored to be invited to speak about #MRgRT in #Rome for upper GI cancers and how we are impacting standard of care

Traditional #MRgRT 🧲 family picture with Luca Boldrini & Michael Chuong !

Thanks for the invitation to #MRinRT24 in wonderful #Rome 🇮🇹!

The April edition of the RTOGF newsletter is available! For #HeadandNeckCancer #Awareness Month, we feature PI interviews for the active KEYSTROKE study & upcoming TRANSPARENT study & an interview w/ New Investigator Spotlight: Dr. Talcott -Read it here: conta.cc/3PJbqYC

What does Dr. Upadhyay have to say about his experience as an RTOGF Communications Intern? Read: ow.ly/HVqI50R6yv8 - Apps are due MAY 1st for future comms interns! $1k stipend + opportunity to get involved with RTOGF #cancerresearch . More info: ow.ly/Va2i50R6yv9

I finally read CROSSFIRE (IRE vs. MRI-guided SBRT after chemo in locally advanced pancreas cancer) in detail.

There are a few issues. Brief thread.

thelancet.com/journals/langa…

The application deadline has been extended for this unique & exciting opportunity for #radonc residents! We are seeking 2 Communications Interns. Deadline for applications is now MAY 1ST! Learn more about the position and how to apply: ow.ly/2oGb50R4zSg

Definitely some lessons learned from our experience with A021501. We thought important to publish these data to inform RTQA design in future pancreas cancer trials which should be a rigorous as possible.

Amazing work by Leila Tchelebi in leading this analysis! Highlights the importance of RTQA for future #PDAC studies especially those using ablative dose

🚨🚨🚨
Brief overview (15 min) of contemporary role and nuanced RT decision making for patients with rectal cancer

🔥🔥Check out video as a pairing with tweetorial attached!

Thanks VuMedi Oncology for the invitation!

#NRG2024 Attendees, don't miss this opportunity: RTOGF is currently accepting applications for RTOGF Communications Interns (2024-2025) App deadline APRIL 1, 2024. Read more about the positions available (2) & apply: ow.ly/TBRJ50QsbcP William A Hall, MD Kristin Higgins Fumiko Ladd Chino, MD

It’s an honor!! 🙏 IJROBP - The Red Journal ASTRO

New in #practicalRO : Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus. #radonc bit.ly/yanagihara1

Exploring #AdaptiveRadiotherapy in cancer care with our latest blog. Insights from Alex Price, Michael Chuong, & Percy Lee MD highlight the evolution and impact: bit.ly/3OERZj5

Radiotherapy & Oncology National Library of Medicine Clinical & Translational Radiation Oncology Frontiers Journal of Clinical Oncology JAMA Oncology JTO & JTO CRR

March 1 Oncology Scan
reviews 3 must know #GI #oncology trials
Neo-PLANET neoadjuvant camrelizumab/CRT for GEJ/gastric
ESPAC5 +/- neoadjuvant for pancreas
SMART MR-guided pancreas RT
Read it at: redjournal.org/article/S0360-…
Michael Chuong Ann Raldow, MD, MPH Dr. Nina Niu Sanford Krishan Jethwa

Lots of work went into this with a super thoughtful team (thanks to fearless co-chair, Twitter/X-less Indrin Chetty) Eric Laugeman Bin Cai Xenia Ray Michael Chuong Jennifer Pursley, PhD Ergys Subashi mmierz (+Bill & Suzy) but we know it may not be perfect yet, so weigh in! 💪🏼